Evogene Ltd. Logo

Evogene Ltd.

EVGN | TA

Overview

Corporate Details

ISIN(s):
IL0011050551
LEI:
Country:
Israel
Address:
13 Gad Feinstein St., Park Rehovot, 7638517 Rehovot
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Evogene develops computational predictive biology solutions for agriculture, health, and sustainability.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-12 16:00
Regulatory News Service
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboratio…
English 135.0 KB
2025-08-12 16:00
Foreign Filer Report
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboratio…
English 36.6 KB
2025-08-12 01:00
Foreign Filer Report
Other Report or Announcement
English 63.2 KB
2025-08-12 01:00
Foreign Filer Report
Other Report or Announcement
English 36.5 KB
2025-07-29 16:00
Report Publication Announcement
Schedules Second Quarter 2025 Financial Results Release and Zoom conference call
English 217.6 KB
2025-07-29 16:00
Report Publication Announcement
Schedules Second Quarter 2025 Financial Results Release and Zoom conference call
English 36.5 KB
2025-07-18 01:00
Foreign Filer Report
Other Report or Announcement
English 180.7 KB
2025-07-18 01:00
Proxy Solicitation & Information Statement
Other Report or Announcement
English 36.7 KB
2025-07-08 16:00
Foreign Filer Report
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activit…
English 173.8 KB
2025-07-08 16:00
Foreign Filer Report
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activit…
English 36.6 KB
2025-06-18 01:01
Proxy Solicitation & Information Statement
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 11, 2025
English 708.7 KB
2025-06-18 01:01
Report Publication Announcement
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 11, 2025
English 36.4 KB
2025-06-18 01:00
Proxy Solicitation & Information Statement
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
English 708.7 KB
2025-06-18 01:00
Foreign Filer Report
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
English 708.7 KB
2025-06-18 01:00
Pre-Annual General Meeting Information
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
English 140.8 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BSF ENTERPRISE PLC Logo BSF ENTERPRISE PLC United Kingdom BSFA
Can-Fite BioPharma Ltd. Logo Can-Fite BioPharma Ltd. Israel CANF
Cantargia Logo Cantargia Sweden CANTA
Captor Therapeutics S.A. Logo Captor Therapeutics S.A. Poland CTX
Carbiotix AB Logo Carbiotix AB Sweden CRBX
Cellectis Logo Cellectis France ALCLS
CELLULAR GOODS PLC Logo CELLULAR GOODS PLC United Kingdom CBX
Celyad Oncology SA Logo Celyad Oncology SA Belgium CYAD
Cereno Scientific AB Logo Cereno Scientific AB Sweden CRNO
Cessatech A/S Logo Cessatech A/S Denmark CESSA